Argenx Se ADR (ARGX)

$372.80 4.20 (1.14%)

16:00 EDT ARGX Stock Quote Delayed 30 Minutes

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Feb 21, 2024

Now could be the time to start looking into these biotech stocks as there are imminent approvals on their clinical trials.

Why Is Argenx (ARGX) Stock Down 25% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Tech Titans Rising: 7 Underrated Stocks Set for Explosive Growth

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 281,322

Day's Range $366.72 - $375.80

52-Week Range $327.73 - $550.76

Dividend & Yield N/A (N/A)

ARGX Stock Predictions, Articles, and Argenx Se ADR News

From InvestorPlace
From the Web

Why Is Argenx (ARGX) Stock Up 27% Today?

By William White, InvestorPlace Writer Jul 17, 2023

Argenx (ARGX) stock is climbing higher on Monday following the release of data from a Phase 1 clinical trial of VYVGART Hytrulo.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jul 17, 2023

It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!

7 Biotech Stocks That Could Cure Your Portfolio Woes

By Josh Enomoto, InvestorPlace Contributor Apr 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jun 7, 2021

It's the start of another busy week of trading and we're kicking it off with a look at the biggest pre-market stock movers for Monday!

7 Pharmaceutical Stocks Working on Their Next Blockbuster

By Alex Sirois, InvestorPlace Contributor Mar 12, 2021

Pharmaceutical stocks are a sector with unique success factors. One factor is developing blockbuster drugs. These 7 are close.

7 “Strong Buy” Healthcare Stocks to Buy Now

By Maya Sasson, Writer, TipRanks May 8, 2020

Amid the COVID-19 pandemic, the investing pros say that it’s still possible to unmask names poised to take off on an upward trajectory.

7 Hot Stocks to Buy in a Cold Market

By Harriet Lefton, Writer, TipRanks Dec 10, 2018

It's hard to believe that there are any stocks left on a current winning streak, but the Street thinks these hot stocks are strong buys.

5 medical stocks growing earnings by triple digits

From MarketBeat Feb 6, 2024

There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning

Regeneron’s Eylea HD, argenx’s Vyvdura approved in Japan

From Seeking Alpha Jan 18, 2024

In Japan, Bayer (BAYRY) and argenx (ARGX) have received regulatory approvals for eye therapy high-dose Eylea and autoimmune therapy, Vyvdura, respectively.

5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond

From The Motley Fool Jan 15, 2024

These five biotech companies could have a lot of room to run.

Argenx stock plunges 23% on failed study for autoimmune disease drug (NASDAQ:ARGX)

From Seeking Alpha Dec 20, 2023

Argenx (ARGX) stock plunged 23% on news that a Phase 3 study for efgartigimod subcutaneous in the treatment of pemphigus fail to meet its primary endpoint. Read more here.

Zai Lab, argenx gain as China adds Vyvgart for reimbursement (NASDAQ:ZLAB)

From Seeking Alpha Dec 13, 2023

Zai Lab (ZLAB) and argenx (ARGX) stocks rise after China adds myasthenia gravis therapy Vyvgart to the National Reimbursement Drug List (NRDL) for 2023. Read more here.

These 2 Stocks Are Falling in a Fading Rally

From The Motley Fool Nov 28, 2023

It's been a good month, but the stock market's looking tired.

ADVERTISEMENT